Delta Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$5.94M Buy
6,871
+141
+2% +$117K 1.36% 13
2024
Q4
$5.2M Buy
+6,730
New +$5.57M 1.22% 14
2024
Q2
Sell
-6,740
Closed -$5.24M 182
2024
Q1
$5.24M Buy
6,740
+7
+0.1% +$4.98K 1.54% 8
2023
Q4
$3.92M Sell
6,733
-88
-1% -$51.4K 1.23% 10
2023
Q3
$3.66M Buy
+6,821
New +$3.51M 1.27% 11
2023
Q2
Sell
-1,489
Closed -$512K 151
2023
Q1
$512K Buy
1,489
+115
+8% +$38.8K 0.2% 90
2022
Q4
$501K Buy
+1,374
New +$487K 0.22% 84

Other funds holding LLY

Delta Financial Group's LLY Position: Q1 2025 in Review

Delta Financial Group increased its Eli Lilly (LLY) stake by 2.1% in Q1 2025, buying an estimated $117K and bringing the position to 6,871 shares worth $5.94M. The position accounts for 1.36% of the portfolio, ranked #13.

Delta Financial Group first reported a position in LLY in Q4 2022 and has held it in 7 quarters since. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Delta Financial Group held 6,871 shares of Eli Lilly worth $5.94M as of Q1 2025.
  • Delta Financial Group bought 141 Eli Lilly shares in Q1 2025, an estimated $117K.
  • Eli Lilly made up 1.36% of Delta Financial Group's portfolio in Q1 2025, its #13 holding.
  • Delta Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 7 quarters since.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Delta Financial Group's 13F filing for Q1 2025, filed 9 May 2025.